Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

VeraLight Announces CE Mark Approval of the SCOUT DS® for Noninvasive Diabetes Screening

July 28, 2011 By Bio-Medicine.Org

ALBUQUERQUE, N.M., July 28, 2011 /PRNewswire/ — VeraLight Inc.,
a privately held medical device company, today announced its SCOUT
DS® Device was granted CE Mark approval for noninvasive
diabetes screening. The easy to operate device needs no blood, does
not require fasting, and yields an immediate result. The patient
simply places their forearm onto the portable table-top unit and a
quantitative result is reported in about three minutes.

Data from 421 study subjects in the CE filing shows SCOUT DS
identified over 60% more people with abnormal glucose tolerance
than either the fasting plasma glucose or hemoglobin A1c tests at
thresholds established by The World Health Organization. The CE
Mark filing was supported by safety and effectiveness studies on a
cohort of 738 study subjects. SCOUT DS is Indicated for Use for the
noninvasive screening of individuals 18 years or older who are at
risk for prediabetes and/or type 2 diabetes to determine whether
diagnostic testing is necessary. Prediabetes is defined as impaired
glucose tolerance.

“SCOUT DS is an efficient, cost-effective alternative to
established blood-based screening methods and we are excited to
begin sales in key markets where the need for clinic-based and mass
population screenings have been well-recognized by the national
health systems and healthcare economists,” says VeraLight CEO David
Van Avermaete.  

SCOUT DS measures skin fluorescence using proprietary technology
to detect biological markers found in skin related to cumulative
glycemic exposure, oxidative stress and microvascular changes.
  A proprietary algorithm adjusts for variations in skin tone
and transforms the measured skin fluorescence and reflectance into
a SCOUT Diabetes Score. Over 10,000 patients have been measured on
the SCOUT DS during its technology development.

The CE Mark approval is proof of conformity that certifies the
product meets European safety, effectiveness, and quality
requi

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech